Image de couverture de livre

Model‐informed precision dosing of carboplatin in cancer patients by leveraging myelosuppression data from electronic health records

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Alessandro De Carlo, Elena Maria Tosca, Mirjam Crul, Tim Schutte, Lia van Zuijlen, Idris Bahce, Medhat M. Said, Jan Buter, Harmen Huls, Paolo Magni, Imke Bartelink
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	British Journal of Clinical Pharmacology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Methotrexate toxicity and glucarpidase: A call for dose optimization
par: Arjen Koppen, et autres
Publié: (2025)

Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiency
par: Annie Siyu Wu, et autres
Publié: (2025)

Model‐based precision dosing and remedial dosing recommendations for delayed or missed doses of isoniazid in Chinese patients with tuberculosis
par: Jin‐Meng Li, et autres
Publié: (2024)

Correction to “Recommended approaches for integration of population pharmacokinetic modelling with precision dosing in clinical practice”
Publié: (2025)

Model‐informed vancomycin precision dosing by population pharmacokinetics combined with machine learning algorithms
par: Lei Shi, et autres
Publié: (2026)

Systematic review and scoring‐based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children
par: Zoë Vander Elst, et autres
Publié: (2026)

A simulation study on model‐informed precision dosing of amikacin for achieving target area under the concentration–time curve
par: Tomoyuki Yamada, et autres
Publié: (2024)

Network‐based precision medicine and systems pharmacology
par: Arvind K. Pandey, et autres
Publié: (2025)

Explainable AI and debiased networks: The ‘last mile’ for precision medicine delivery
par: Siyi Liu, et autres
Publié: (2025)

A subtype‐selective photoswitchable agonist for precise manipulation of GABAA receptors
par: Simon Miguel M. Lopez, et autres
Publié: (2025)

The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases
par: Jiuguo Lin, et autres
Publié: (2024)

DysRegNet: Patient‐specific and confounder‐aware dysregulated network inference towards precision therapeutics
par: Johannes Kersting, et autres
Publié: (2024)

Population pharmacokinetics of TBAJ‐587 and its main metabolites—Evaluation of different loading dose strategies and early dose selection
par: Albin A. M. Leding, et autres
Publié: (2025)

A high‐precision view of intercompartmental drug transport via simultaneous, seconds‐resolved, in situ measurements in the vein and brain
par: Julian Gerson, et autres
Publié: (2024)

The feasibility of pharmacokinetic‐based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trial
par: Alexandra Power‐Hays, et autres
Publié: (2025)

Practical dose ranges supporting target vancomycin exposure with AUC‐guided dosing in overweight and obese patients: A multicentre retrospective study
par: Aiju Endo, et autres
Publié: (2026)

Determination of the optimal obesity‐adjusted dosing weight for enoxaparin
par: Gregory W. Roberts, et autres
Publié: (2024)

Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patients
par: Jaap W. A. Mouton, et autres
Publié: (2025)

Opening closed inward rectifier potassium channel doors
par: Anna Stary‐Weinzinger, et autres
Publié: (2026)

Cefuroxime axetil dosing regimens and probability of target attainment in adults and children
par: Sven C. van Dijkman, et autres
Publié: (2025)

Pharmacokinetics of long‐acting cabotegravir and rilpivirine in seminal plasma throughout the dosing interval
par: N. Neverette, et autres
Publié: (2025)

Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin‐resistant tuberculosis
par: Megan Palmer, et autres
Publié: (2025)

Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
par: Clifford G. Banda, et autres
Publié: (2024)

Fixed dosing of alpelisib for children with vascular anomalies: Can we do better?
par: Amandine Remy, et autres
Publié: (2025)

The development and evaluation of dose‐prediction tools for allopurinol therapy (Easy‐Allo tools)
par: Daniel F. B. Wright, et autres
Publié: (2024)

Antiviral dose response against CMV infection varies with the timing of treatment initiation
par: L. Sudarsono, et autres
Publié: (2025)

Case report: Dolutegravir dosing post‐Roux‐en‐Y gastric bypass surgery
Publié: (2024)

Low‐dose amitriptyline: A potential therapeutic option for chronic pain in older people
par: Takayuki Suga, et autres
Publié: (2024)

The case of dolutegravir plus darunavir antiretroviral regimens: Is it always useful to double the drug doses?
Publié: (2024)

A real‐world data‐driven approach to optimizing enoxaparin dosing in burn patients
par: Babajide Shenkoya, et autres
Publié: (2025)

Mind the gap: Adherence to denosumab dosing and cessation guidelines in Australian residential aged care
par: Marea O'Donnell, et autres
Publié: (2026)

Bleeding in patients on concurrent treatment with a selective serotonin reuptake inhibitor (SSRI) and low‐dose acetylsalicylic acid (ASA) compared with SSRI or low‐dose ASA alone—A systematic review and meta‐analysis
par: Magnus A. B. Axelsson, et autres
Publié: (2024)

Application of paediatric cetirizine PBPK model to guide precision medicine and understand renal P‐glycoprotein ontogeny
par: Yafen Li, et autres
Publié: (2026)

A quantitative model‐based approach for adavosertib dose selection in patients with uterine serous carcinoma
par: Shankar Lanke, et autres
Publié: (2025)

Plasma apixaban concentrations and thrombin generation assay parameters in response to dose reduction for atrial fibrillation
par: Muhan Yeo, et autres
Publié: (2024)

Pentoxifylline dose finding trial in preterm neonates with suspected late onset sepsis (PTX‐trial)
par: Serife Kurul, et autres
Publié: (2025)

Temporal effects of errors in estimating kidney function after critical illness on drug dosing categories
par: Ryusei Mikami, et autres
Publié: (2025)

Development of a novel tyrosine kinase 2 inhibitor ARTS‐011 and its first‐in‐human single and multiple ascending dose Phase I study to evaluate the tolerability, safety, pharmacokinetic profile and food effects
par: Zhili Jin, et autres
Publié: (2026)

Design of a pharmacokinetic/pharmacodynamic model for administration of low dose peripheral norepinephrine during general anaesthesia
par: Jona Joachim, et autres
Publié: (2024)

Evaluation of the acute effects of single‐dose TPN171 on semen quality in healthy Chinese male volunteers
par: Yuzhuo Yang, et autres
Publié: (2025)